Free Trial

Addus HomeCare (NASDAQ:ADUS) Upgraded at StockNews.com

Addus HomeCare logo with Medical background

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS - Free Report) from a hold rating to a buy rating in a research report sent to investors on Wednesday.

Other equities research analysts also recently issued research reports about the company. KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective for the company. Oppenheimer increased their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. Macquarie reissued an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Royal Bank of Canada reissued an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $131.63.

Get Our Latest Analysis on Addus HomeCare

Addus HomeCare Stock Performance

NASDAQ ADUS traded down $2.05 during trading hours on Wednesday, reaching $120.90. 99,255 shares of the company's stock were exchanged, compared to its average volume of 130,362. The company's 50-day moving average is $125.90 and its two-hundred day moving average is $124.32. Addus HomeCare has a one year low of $85.94 and a one year high of $136.12. The company has a market capitalization of $2.19 billion, a price-to-earnings ratio of 28.14, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the prior year, the firm posted $1.03 EPS. The business's revenue was up 7.1% on a year-over-year basis. Research analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company's stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company's stock.

Institutional Trading of Addus HomeCare

Large investors have recently bought and sold shares of the business. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock valued at $26,000 after buying an additional 88 shares in the last quarter. Quarry LP acquired a new stake in shares of Addus HomeCare during the third quarter valued at about $28,000. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $31,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $44,000. Finally, Farther Finance Advisors LLC boosted its stake in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after purchasing an additional 366 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should you invest $1,000 in Addus HomeCare right now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines